34291-02-6 Usage
Description
BUTIROSIN A is a butirosin derivative, specifically a neamine compound substituted at position 2 by a beta-D-xylofuranosyl and at position 4 by an (S)-2-hydroxy-4-aminobutyryl group. It is a type of aminoglycoside antibiotic, known for its potent antibacterial properties.
Uses
Used in Pharmaceutical Industry:
BUTIROSIN A is used as an antibiotic for treating various bacterial infections. Its potent antibacterial properties make it effective against a wide range of gram-negative and gram-positive bacteria, including those that are resistant to other antibiotics.
Used in Veterinary Medicine:
In the veterinary field, BUTIROSIN A is used as an animal health supplement to prevent and treat bacterial infections in livestock and poultry. Its broad-spectrum activity helps maintain the overall health and well-being of animals, contributing to the productivity and sustainability of the livestock industry.
Used in Research and Development:
BUTIROSIN A is also utilized in the research and development of new antibiotics and pharmaceutical compounds. Its unique structure and properties make it a valuable tool for studying the mechanisms of action and resistance in bacteria, as well as for designing novel drugs with improved efficacy and reduced side effects.
Check Digit Verification of cas no
The CAS Registry Mumber 34291-02-6 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 3,4,2,9 and 1 respectively; the second part has 2 digits, 0 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 34291-02:
(7*3)+(6*4)+(5*2)+(4*9)+(3*1)+(2*0)+(1*2)=96
96 % 10 = 6
So 34291-02-6 is a valid CAS Registry Number.
InChI:InChI=1/C21H41N5O12/c22-2-1-8(28)19(34)26-7-3-6(24)17(37-20-11(25)15(32)13(30)9(4-23)35-20)18(12(7)29)38-21-16(33)14(31)10(5-27)36-21/h6-18,20-21,27-33H,1-5,22-25H2,(H,26,34)/t6-,7+,8-,9+,10+,11+,12-,13+,14-,15+,16+,17+,18+,20+,21-/m0/s1
34291-02-6Relevant articles and documents
Combined chemical-enzymatic assembly of aminoglycoside derivatives with N-1-AHB side chain
Nudelman, Igor,Chen, Lilach,Llewellyn, Nicholas M.,Sahraoui, El-Habib,Cherniavsky, Marina,Spencer, Jonathan B.,Baasova, Timor
experimental part, p. 1682 - 1688 (2009/08/12)
A series of unprotected pseudo-disaccharides and pseudo-trisaccharides of 2-deoxystreptamine-containing aminoglycosides have been selectively acylated at the N-1 position with the valuable (S)-4-amino-2-hydroxybutanoyl (AHB) pharmacophore by using the recombinant BtrH and BtrG enzymes from butirosin biosynthesis in combination with a synthetic acyl donor. The process was optimized by performing two enzymatic steps in a sequential manner without purification of the intermediate product.
Synthesis of butirosin B and its 3',4' dideoxy derivative
Ikeda,Tsuchiya,Umezawa,Umezawa
, p. 3136 - 3138 (2007/10/10)
-